Samumed Saç. It came out of the shadows in 2016 with a war chest of 220. The Company has discovered new targets and biological processes in the Wnt pathway allowing the team to develop small molecule drugs that potentially address numerous degenerative conditions as well.
The South African Municipal Workers Union Medical Scheme SAMWUMED is a financially healthy fully-funded national-accredited and self-administered medical aid scheme which covers approximately 75 000 lives throughout South Africa. Biosplice Therapeutics has produced fresh biological insights and unique chemical equity that delivers therapeutic modulation of alternative splicing by targeting the CLKDYRK family kinases. SAN DIEGO May 22 2020 GLOBE NEWSWIRE -- Samumed LLC announced today the publication of results from the Phase 2a trial of lorecivivint an investigational CLKDYRK1A inhibitor.
These kinases govern the selection of tissue-specific and disease-selective RNA splice-sites defining them as druggable targets within the command and.
The South African Municipal Workers Union Medical Scheme SAMWUMED is a financially healthy fully-funded national-accredited and self-administered medical aid scheme which covers approximately 75 000 lives throughout South Africa. In 2021 the company is supposed to release much anticipated results of Phase 3 clinical trials for its hair loss product. Samumed came out with a bang a couple years ago when it boldly announced a couple of anti-aging programs and a 12 billion valuation. April 16 2021 admin 75 Comments.